Lung cancer is a common life-threatening tumor with high malignancy and high invasiveness. Long non-coding RNAs (lncRNAs) are involved in almost every stage of tumor initiation and progression. Here, we identified an antisense lncRNA, MetaLnc9 antisense (Metalnc9-AS), which arises from the antisense strand of Metalnc9, located on chr9q34.11, while its biological function and mechanism are not clear in lung cancer. In this study, we demonstrated that the expression of Metalnc9-AS was upregulated in non-small cell lung cancer (NSCLC) tissues compared with corresponding non-tumorous tissues. The gain of MetaLnc9-AS was highly associated with the malignant features of NSCLC. Overexpression of MetaLnc9-AS enhanced tumor metastasis in vitro and in vivo. Mechanically, MetaLnc9-AS could form an RNA–RNA hybrid with its cognate sense counterpart, MetaLnc9, to regulate its expression in NSCLC cells, and that such complexes were protected from ribonuclease degradation. Thus, Metalnc9-AS might be a potential and effective treatment for NSCLC.
Get full access to this article
View all access options for this article.
References
1.
BadeB.C., and Dela CruzC.S. (2020). Lung cancer 2020: Epidemiology, etiology, and prevention. Clin Chest Med, 41, 1–24.
2.
BartaJ.A., PowellC.A., and WisniveskyJ.P. (2019). Global epidemiology of lung cancer. Ann Glob Health 85,8.
3.
Blandin KnightS., CrosbieP.A., BalataH., ChudziakJ., HussellT., and DiveC. (2017). Progress and prospects of early detection in lung cancer. Open Biol 7,170070.
4.
CamblongJ., IglesiasN., FickentscherC., DieppoisG., and StutzF. (2007). Antisense RNA stabilization induces transcriptional gene silencing via histone deacetylation in S. cerevisiae. Cell, 131, 706–717.
5.
EngreitzJ.M., OllikainenN., and GuttmanM. (2016). Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat Rev Mol Cell Biol, 17, 756–770.
6.
GeZ., ChengZ., YangX., HuoX., WangN., WangH., et al. (2017). Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma. Cancer Sci, 108, 653–662.
7.
GoodallG.J., and WickramasingheV.O. (2021). RNA in cancer. Nat Rev Cancer, 21, 22–36.
8.
GuptaR.A., ShahN., WangK.C., KimJ., HorlingsH.M., WongD.J., et al. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071–1076.
9.
HuX., SoodA.K., DangC.V., and ZhangL. (2018). The role of long noncoding RNAs in cancer: the dark matter matters. Curr Opin Genet Dev, 48, 8–15.
10.
HuangB., SongJ.H., ChengY., AbrahamJ.M., IbrahimS., SunZ., et al. (2016). Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression. Oncogene, 35, 4927–4936.
11.
JadalihaM., GholamalamdariO., TangW., ZhangY., PetracoviciA., HaoQ., et al. (2018). A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability. PLoS Genet 14,e1007802.
12.
KatayamaS., TomaruY., KasukawaT., WakiK., NakanishiM., NakamuraM., et al. (2005). Antisense transcription in the mammalian transcriptome. Science, 309, 1564–1566.
13.
KongL., ZhangY., YeZ.-Q., LiuX.-Q., ZhaoS.-Q., WeiL., et al. (2007). CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res, 35, W345–W349.
14.
LiY., BaptistaR.P., SaterialeA., StriepenB., and KissingerJ.C. (2021). Analysis of long non-coding rna in cryptosporidium parvum reveals significant stage-specific antisense transcription. Front Cell Infect Microbiol 10,608298.
15.
LinM.F., JungreisI., and KellisM. (2011). PhyloCSF: a comparative genomics method to distinguish protein coding and non-coding regions. Bioinformatics (Oxford, England), 27, i275–i282.
16.
ModarresiF., FaghihiM.A., Lopez-ToledanoM.A., FatemiR.P., MagistriM., BrothersS.P., et al. (2012). Natural antisense inhibition results in transcriptional de-repression and gene upregulation. Nat Biotechnol, 30, 453–459.
17.
NieW., GeH.-j., YangX.-q., SunX., HuangH., TaoX., et al. (2016). LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett, 371, 99–106.
18.
OkuyamaT., SakamotoR., KumagaiK., NishizawaM., KimuraT., SugieT., et al. (2020). EPHA2 antisense RNA modulates EPHA2 mRNA levels in basal-like/triple-negative breast cancer cells. Biochimie, 179, 169–180.
19.
PanJ., and ZhaoL. (2021). Long non-coding RNA histone deacetylase 4 antisense RNA 1 (HDAC4-AS1) inhibits HDAC4 expression in human ARPE-19 cells with hypoxic stress. Bioengineered, 12, 2228–2237.
20.
ParkS.-M., ChoiE.-Y., BaeD.-H., Sohn HyunA., KimS.-Y., and KimY.-J. (2018). The LncRNA EPEL promotes lung cancer cell proliferation through E2F target activation. Cell Physiol Biochem, 45, 1270–1283.
21.
PelechanoV., and SteinmetzL.M. (2013). Gene regulation by antisense transcription. Nat Rev Genet, 14, 880–893.
22.
QuinodozS., and GuttmanM. (2014). Long noncoding RNAs: an emerging link between gene regulation and nuclear organization. Trends Cell Biol, 24, 651–663.
23.
RenZ., LiuX., SiY., and YangD. (2020). Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis. Artif Cells Nanomed Biotechnol, 48, 572–583.
24.
SeilerJ., BreinigM., Caudron-HergerM., Polycarpou-SchwarzM., BoutrosM., and DiederichsS. (2017). The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance. Nucleic Acids Res, 45, 5458–5469.
25.
SiegelR., MaJ., ZouZ., and JemalA. (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9–29.
26.
SuW.-Y., LiJ.-T., CuiY., HongJ., DuW., WangY.-C., et al. (2012). Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer. Cell Res, 22, 1374–1389.
27.
TanB.-S., YangM.-C., SinghS., ChouY.-C., ChenH.-Y., WangM.-Y., et al. (2019). LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P. Oncogene, 38, 5612–5626.
28.
TsaiM.-C., ManorO., WanY., MosammaparastN., WangJ.K., LanF., et al. (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science (New York, NY), 329, 689–693.
29.
VillegasV.E., and ZaphiropoulosP.G. (2015). Neighboring gene regulation by antisense long non-coding RNAs. Int J Mol Sci, 16, 3251–3266.
30.
WangL., ParkH.J., DasariS., WangS., KocherJ.-P., and LiW. (2013). CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res 41,e74.
31.
WiluszJ.E., SunwooH., and SpectorD.L. (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 23, 1494–1504.
32.
XiQ., GaoN., ZhangX., ZhangB., YeW., WuJ., et al. (2014). A natural antisense transcript regulates acetylcholinesterase gene expression via epigenetic modification in Hepatocellular Carcinoma. Int J Biochem Cell Biol, 55, 242–251.
33.
YuT., ZhaoY., HuZ., LiJ., ChuD., ZhangJ., et al. (2017). MetaLnc9 facilitates lung cancer metastasis via a PGK1-activated AKT/mTOR pathway. Cancer Res, 21, 5784–5794.
34.
ZhangX., WangW., ZhuW., DongJ., ChengY., YinZ., et al. (2019). Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci 22,5573.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
